We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » AstraZeneca Wins Patent Case Over Symbicort Against Mylan, Kindeva
AstraZeneca Wins Patent Case Over Symbicort Against Mylan, Kindeva
AstraZeneca (AZ) has won a patent lawsuit in a federal court against Mylan Pharmaceuticals and Kindeva Drug Delivery, which were planning to make generic versions of AZ’s blockbuster asthma drug Symbicort (budesonide/formoterol).